Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-27T13:18:59.110Z Has data issue: false hasContentIssue false
  • English
  • Français

Attitudes et perception de contrôle des personnes âgées envers la prise de médicaments à action anxiolytique, sédative et hypnotique (ASH)

Published online by Cambridge University Press:  07 April 2011

Marilyn Guindon  and
Philippe Cappeliez
Marilyn Guindon*
Affiliation:
Université d’Ottawa
Philippe Cappeliez
Affiliation:
Université d’Ottawa
*
*La correspondance et les demandes de tirés-à-part doivent être adressées à : / Correspondence and requests for offprints should be sent to: Marilyn Guindon, Ph, D. Faculté des Sciences Humaines Université St-Paul Ottawa, ON K1S 1C4 (mguindon@ustpaul.ca)
Get access Rights & Permissions [Opens in a new window]

Abstract

This study examines the importance of variables from the Theory of Planned Behaviour (i.e.,attitudes toward behaviour, subjective norms, and perceived control) for the prediction of consumption of anxiolytic and sedative-hypnotic (ASH) medications in a sample of older persons, aged 69 years on average, 62 consumers and 92 non-consumers. A favourable attitude toward ASH and a sense of having less control regarding these drugs predict both current usage and intention to continue. Perceived control predicts intention to start consumption of ASH in current non-consumers. This study underlines the importance of considering the role of the older person’s decisional power in the consumption of these medications.

Résumé

Cette étude examine la contribution des variables de la Théorie du Comportement Planifié (attitudes envers le comportement, normes subjectives, perception de contrôle) à la prédiction de la consommation de médicaments à action anxiolytique, sédative et hypnotique (ASH) au sein d’un échantillon de personnes âgées en moyenne de 69 ans, constitué de 62 personnes qui consomment ces médicaments et de 92 qui n’en consomment pas. Les résultats indiquent que, chez les consommateurs, des attitudes favorables à l’égard des ASH et le fait de ressentir peu de contrôle envers cette consommation en prédisent le recours actuel, de même que l’intention de continuer. Par ailleurs, la perception de contrôle prédit l’intention de débuter la prise d’ASH chez les non-consommateurs. Cette étude souligne l’importance de tenir compte du pouvoir décisionnel des personnes âgées quant à la prise de ces médicaments.

Keywords

attitudeanxiolytiquesconsommationperception de contrôlepersonnes âgéessédatif-hypnotiqueattitudeanxiolyticconsumptionelderlyperceived controlsedative-hypnotic
Type
Regular Articles / Articles réguliers
Information
Canadian Journal on Aging / La Revue canadienne du vieillissement , Volume 30 , Issue 1 , March 2011 , pp. 113 - 126
Copyright
Copyright © Canadian Association on Gerontology 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Références

Ajzen, I. (1988). Attitudes, personality and behavior. Milton Keynes, UK: Open University Press.Google Scholar
Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior & Human Decision Processes, 50, 179–211.CrossRefGoogle Scholar
Ajzen, I. (2001). Nature and operation of attitudes. Annual Review of Psychology, 52, 27–58.Google Scholar
Ajzen, I. (2002). Perceived behavioral control, self-efficacy, locus of control, and the theory of planned behavior. Journal of Applied Social Psychology, 32(4), 665–683.Google Scholar
Ajzen, I., et Manstead, A.S.R. (2007). Changing health-related behaviours: An approach based on the theory of planned behavior. van den Bos, Dans K., Hewstone, M., de Wit, J., Schut, H., et Stroebe, M. (Eds.), The scope of social psychology: Theory and applications (pp. 43–63). New York: Psychology Press.Google Scholar
Allard, J., Allaire, D., Leclerc, G., et Langlois, S.-P. (1995). The influence of family and social relationships on the consumption of psychotropic drugs by the elderly. Archives of Gerontology and Geriatrics, 20, 193–204.Google Scholar
Armitage, C.J., et Christian, J. (2003). From attitudes to behaviour: Basic and applied research on the theory of planned behaviour. Current Psychology, 22, 187–195.Google Scholar
Armitage, C.J., et Conner, M. (2001). Efficacy of the theory of planned behaviour: A meta-analytic review. British Journal of Social Psychology, 40, 471–499.Google Scholar
Beall, C.S., Baumhover, L.A., Maxwell, A.J., et Pieroni, R.E. (1996). Normal versus pathological aging: Knowledge of family practice residents. The Gerontologist, 36(1), 113–117.Google Scholar
Blais, F., Gendron, L., Mimeault, V., et Morin, C.M. (1997). Évaluation de l’insomnie: Validation de trois questionnaires. L’Encéphale, 23(6), 447–453.Google Scholar
Blue, C.L., Marrero, D.G., & Black, D.R. (2008). Physical activity belief scales for diabetes risk: Development and psychometric testing. Health Education & Behavior, 35(3), 316–331.Google Scholar
Bouchard, S., Gauthier, J., Ivers, H., et Paradis, J. (1996). Adaptation de l’inventaire d’anxiété situationnelle et de trait aux personnes âgées de 65 ans et plus (IASTA-Y65+). Canadian Journal on Aging, 15, 500–513.CrossRefGoogle Scholar
Bouchard, S., Ivers, H., Gauthier, J., Pelletier, M.-H., et Savard, J. (1998). Psychometric properties of the French version of the State-Trait Anxiety Inventory (form Y) adapted for older adults. Canadian Journal on Aging, 17, 440–453.Google Scholar
Bourque, P., Blanchard, L., Sadéghi, M.-R., & Arseneault, A.-M. (1991). État de santé, consommation de médicaments et symptômes de la dépression chez les personnes âgées. Canadian Journal on Aging/La Revue Canadienne du Vieillissement, 10(4), 308–319.Google Scholar
Bradley, C. (1992). Factors which influence the decision whether or not to prescribe: The dilemma facing general practitioners. British Journal of General Practice, 422, 454–458.Google Scholar
Brim, O.G., Ryff, C.D., & Kessler, R.C. (2004). How healthy are we?: A national study of well-being at midlife. Chicago, IL: University of Chicago Press.Google Scholar
Buysse, D.J., Reynolds, C.F. III, Monk, T.H., Berman, S.R., et Kupfer, D.J. (1989). The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Research, 28, 193–213.Google Scholar
Caplan, R.D., Abbey, A., Abramis, D.J., Andrews, F.M., Conway, T.L., et French, J.R.P. Jr. (1984). Tranquilizer use and well-being: A longitudinal study of social and psychological effects. Institute for Social Research, Ann Arbor, University of Michigan.Google Scholar
Cappeliez, P., Quintal, M., Blouin, M., Gagné, S., Bourgeois, A., Finlay, M., et al. . (1996). Les propriétés psychométriques de la version française du Modified Mini-Mental State (3MS) avec des patients âgés suivis en psychiatrie gériatrique. Revue Canadienne de Psychiatrie, 41, 114–121.Google Scholar
CFES (2001). Baromètre santé 2000, Paris, France: CFES.Google Scholar
Chinburapa, V., Larson, L.N., & Brucks, M. (1993). Physician prescribing decisions: The effects of situational involvement and task complexity on information acquisition and decision making. Social Science and Medicine, 36(11), 1473–1482.Google Scholar
Clinthorne, J.K., Cisin, J.H., Balter, M.B., Mellinger, G.D., et Unlenhuth, E.H. (1986). Changes in popular attitudes and beliefs about tranquilizers. Archives of General Psychiatry, 43(6), 527–532.Google Scholar
Cloutier, C., & Leroux, Y. (1998). Prédiction de l’intention créatrice à l’aide du modèle du comportement planifié de Ajzen. Revue Canadienne des Sciences du Comportement, 30(3), 182–192.Google Scholar
Cohen, D., & Collin, J. (1997). Les toxicomanies reliées aux médicaments psychotropes chez les personnes âgées, les femmes et les enfants: Recension et analyse des écrits. Québec, Canada: Gouvernement du Québec, Ministère de la Santé et des Services Sociaux.Google Scholar
Conseil du Médicament du Québec. (source consultée en septembre 2004). Usage optimal des médicaments. Disponible à: http://www.cdm.gouv.qc.ca/site/download.php?f=d37faab2dceccb57728ad57f2fbab91fGoogle Scholar
Cormack, M.A., & Howells, E. (1992). Factors linked to the prescribing of benzodiazepines by general practice principals and trainees. Family Practice, 9(4), 466–471.Google Scholar
Crabb, R. (2008). Utilization of mental health care services among older adults with depression in Canada. Thèse de doctorat inédite, Université d’Ottawa: École de psychologie, Faculté des sciences sociales.Google Scholar
Davidson, W., Molly, D.W., Somers, G., & Bédard, M. (1994). Relation between physician characteristics and prescribing for elderly people in New Brunswick. Canadian Medical Association Journal, 150(6), 917–921.Google Scholar
Dealberto, M.-J., McAvay, G.J., Seeman, T., & Berkman, L. (1997). Psychotropic drug use and cognitive decline among older men and women. International Journal of Geriatric Psychiatry, 12(5), 567–574.Google Scholar
Fortier, M.S., Kowal, J., Lemyre, L., & Orpana, H.M. (2009). Intentions and actual physical activity behavior change in a community-based sample of middle-aged women: Contributions from the Theory of Planned Behavior and Self-Determination Theory. International Journal of Sport and Exercise Psychology, 7, 46–67.Google Scholar
Fortin, D., Préville, M., Ducharme, C., Hébert, R., Allard, J., Grégoire, J.-P., et al. . (2005). Facteurs associés à la consommation de courte et de longue durée des benzodiazépines chez les personnes âgées du Québec. Canadian Journal on Aging, 24(2), 103–114.Google Scholar
Fortin, D., Préville, M., Ducharme, C., Hébert, R., Allard, J., Grégoire, J.-P., Trottier, L., & Bérard, A. (2006). Facteurs associés à la consommation de courte et de longue durée de benzodiazépines chez les personnes âgées du Québec. La Revue Canadienne du Vieillissement, 24(2), 103–114.Google Scholar
Gauthier, J., & Bouchard, S. (1993). Adaptation canadienne-française de la forme révisée du State-Trait Anxiety Inventory de Spielberger. Revue Canadienne des Sciences du Comportement, 25(4), 559–578.Google Scholar
Godin, G., et Kok, G. (1996). The theory of planned behavior: A review of its application to health-related behaviors. American Journal of Health Promotion, 11(2), 87–98.Google Scholar
Gollwitzer, P.M., (1993). Goal achievement: The role of intentions. In Stroebe, W. et Hewstone, M. (Eds.), European review of social psychologyVol. 4, pp. 141–185. Chichester, UK: Wiley.Google Scholar
Gray, S.L., Eggen, A.E., Blough, D., Buchner, D., et LaCroix, A.Z. (2003). Benzodiazepine use in older adults enrolled in a health maintenance organization. American Journal of Geriatric Psychiatry, 11(5), 568–576.Google Scholar
Grenier, L., et Barbeau, G. (1991). Effets indésirables des médicaments. Barbeau, Dans G. et Guimond, J., Mallet, L. (Eds.), Médicaments et personnes âgées (chapitre 13, pp. 159–174). Canada: Edisem et Manoine, Québec, Les Presses de l’Université LavalGoogle Scholar
Gustafsson, T.M., Isacson, D.G.L., Thorslund, M., et Sörbom, D. (1996). Factors associated with psychotropic drug use among the elderly living at home. Journal of Applied Gerontology, 15(2), 238–254.Google Scholar
Hales, D., Evenson, K.R., Wen, F., et Wilcox, S. (2010). Postpartum physical activity: Measuring theory of planned behavior constructs. American Journal of Health Behavior, 34(4), 387–401.Google Scholar
Harris, D.K., Changas, P.S., et Palmore, E.B. (1996). Palmore’s first fact on aging quiz in a multiple-choice format. Educational Gerontology, 22, 575–589.Google Scholar
Hartzema, A.G., et Christensen, D.B. (1983). Non-medical factors associated with the prescribing volume among family practitioners in an HMO. Medical Care, 21, 990–1000.Google Scholar
Hébert, R., Bravo, G., et Girouard, D. (1992). Validation de l’adaptation française du modified mini-mental state (3MS). La Revue de Gériatrie, 17(8), 443–450.Google Scholar
Heckhausen, H. (1991). Motivation and action. New York: Springer.Google Scholar
Hemmelgarn, B., Suissa, S., Huang, A., Boivin, J.F., et Pinard, G. (1997). Benzodiazepine use and the risk of motor vehicle crash in the elderly. The Journal of the American Medical Association, 278, 27–31.Google Scholar
Hendricks, J., Johnson, T.P., Sheahan, S.L., et Coons, S.J. (1991). Medication use among older persons in congregate living facilities. Journal of Geriatric Drug Therapy, 6, 47–61.Google Scholar
Illife, S., Curran, H.V., Collins, R., Yuen, K.S., Fletcher, S., et Woods, B. (2004). Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: Findings from interviews with service users and providers. Aging & Mental Health, 8(3), 242–248.Google Scholar
Iwashyna, T.J., et Christakis, N.A. (2003). Marriage, widowhood, and health-care use. Social Science and Medicine, 57(11), 2137–2147.Google Scholar
Jorm, A.F., Christensen, H., Griffiths, K.M., et Rodgers, B. (2002). Effectiveness of complementary and self-help treatments for depression. Medical Journal of Australia, 176, S84–S96.Google Scholar
Jorm, A.F., Grayson, D., Creasey, H., Waite, L., et Broe, G.A. (2000). Long-term benzodiazepine use by elderly people living in the community. Australian and New Zealand Journal of Public Health, 24(1), 7–10.Google Scholar
Keefe, F.J., Smith, S.J., Buffington, A.L.H., Gibson, J., Studts, J.L., et Caldwell, D.S. (2002). Recent advances and future directions in the biopsychosocial assessment and treatment of arthritis. Journal of Consulting and Clinical Psychology, 70, 640–655.Google Scholar
Kim, R.-B., Park, K.-S., Hong, D.-Y., Lee, C.-H., et Kim, J.-R. (2010). Factors associated with cancer screening intention in eligible persons for national cancer screening program. Journal of Preventive Medicine and Public Health, 43(1), 62–72.Google Scholar
Laurier, C., Dumas, J., et Grégoire, J.P. (1992). Factors related to benzodiazepine use in Quebec – a secondary analysis of survey data. Journal of Pharmacoepidemiology, 2, 73–86.Google Scholar
Lechevallier, N., Fourrier, A., et Berr, C. (2003). Utilisation de benzodiazépines chez les sujets âgés: Données de la cohorte EVA. Revue Épidémiologique de Santé Publique, 51, 317–326.Google Scholar
Légaré, F., Dodin, S., et Godin, G. (1995). Prise de l’hormonothérapie de remplacement à la ménopause: Problématique et développement d’un protocole de recherche visant à en étudier les déterminants. Mémoire de maîtrise inédit, Université Laval, Québec: Département de médecine sociale et préventive.Google Scholar
Légaré, F., Godin, G., Dodin, S., Turcot-Lemay, L., et Laperrière, L. (2003). Adherence to hormone replacement therapy: A longitudinal study using the theory of planned behavior. Psychology and Health, 18(3), 351–371.Google Scholar
Manheimer, D.I., Davidson, S.T., Balter, M.B., Mellinger, G.D., Cisin, I.H., et Parry, H.J. (1973). Popular attitudes and beliefs about tranquilizers. American Journal of Psychiatry, 130(11), 1246–1253.Google Scholar
Marinier, R.L., Pihl, R.O., Wilford, C., et Lapp, J.E. (1985). Psychotropic drug use by women: Demographic, lifestyle, and personality correlates. Drug Intelligence and Clinical Pharmacy, 19, 40–45.CrossRefGoogle ScholarPubMed
Mishara, B. (1996). L’écologie familiale et la consommation de médicaments chez les personnes âgées: Commentaires sur un facteur important ignoré dans les recherches et les projets de prévention. Santé Mentale au Québec, 22(1), 200–215.Google Scholar
Monette, J., Tamblyn, R.M., McLoed, P.J., Gayton, D.C., et Laprise, R. (1994). Do medical education and practice characteristics predict innapropriate prescribing of sedative-hypnotics for the elderly? Academic Medicine, 69(Suppl. 10), s10–s12.CrossRefGoogle Scholar
Morin, C.M., Bastien, C., Guay, B., Radouco-Thomas, M., Leblanc, J., et Vallières, A. (2004). Insomnia and chronic use of benzodiazepines: A randomized clinical trial of supervised tapering, cognitive-behavior therapy, and a combined approach to facilitate benzodiazepine discontinuation. American Journal of Psychiatry, 161, 332–342.Google Scholar
Neutel, C.I. (2005). The epidemiology of long-term benzodiazepine use. International Review of Psychiatry, 17(3), 189–97.Google Scholar
Ohayon, M.M., & Caulet, M. (1996). Psychotropic medication and insomnia complaints in two epidemiological studies. Canadian Journal of Psychiatry, 41(7), 457–464.Google Scholar
Oude Voshaar, R., Gorgels, W., Mol, A., van Balkom, A., Breteler, M., van de Lisdonk, E., et al. . (2006). Predictors of relapse after discontinuation of long-term benzodiazepine use by minimal intervention: A 2-year follow-up study. Family Practice, 20(4), 370–372.Google Scholar
Palmore, E.B. (1981). The facts on aging quiz: Part two. The Gerontologist, 21(4), 431–437.Google Scholar
Parr, J.M., Kavanagh, D.J., Young, R.M., & McCafferty, K. (2006). Views of general practitioners and benzodiazepine users on benzodiazepines: A qualitative analysis. Social Science & Medicine, 62, 1237–1249.Google Scholar
Pérodeau, G., Grenon, É., Préville, M., Savoie-Zajc, L., Forget, H., Green-Demers, I., et al. . (2006). Consommation de benzodiazépines: Attitudes des médecins, pharmaciens et consommateurs. In 8ième Congrès international francophone de gérontologie et de gériatrie. Québec:Canada.Google Scholar
Pérodeau, G., King, S., et Ostoj, M. (1992). Stress and psychotropic drug use among the elderly: An exploratory model. Canadian Journal on Aging/Revue Canadienne du Vieillissement, 11(4), 347–369.Google Scholar
Pérodeau, G., et Ostoj, M. (1990). Facteurs psychosociaux reliés à la consommation de psychotropes par les personnes âgées en maintien à domicile: Rapport de recherche présenté au Conseil Québécois de la recherche sociale. Verdun, Montréal: Centre de recherche de l’Hôpital Douglas.Google Scholar
Pérodeau, G., et Ostoj, M. (1992). Adaptation au stress et utilisation de psychotropes par les personnes âgées. Verdun, Canada: Centre de recherche de l’Hôpital Douglas.Google Scholar
Pérodeau, G., Paradis, I., Ducharme, F., Collin, J., & St-Jacques, J. (2003). Dynamique familiale et médicament psychotropes: les femmes âgées consommatrices et leurs aidantes. In Levy, J., Maisonneuve, D., Bilodeau, H., et Garnier, C. (Éds.), Enjeux psychosociaux de la santé (pp. 275–286). Presses de l’Université du Québec.Google Scholar
Ray, W.A., Griffin, M.R., et Downey, W. (1989). Benzodiazepines of long and short elimination half-life and the risk of hip fracture. Journal of the American Medical Association, 262, 3303–3307.Google Scholar
Shepperd, B.H., Hartwick, J., et Warshaw, P.R. (1988). The theory of reasoned action: A meta-analysis of past research with recommendations for modifications and future research. Journal of Consumer Research, 15, 325–343.Google Scholar
Simon, G.E., et Ludman, E.J. (2006). Outcome of new benzodiazepine prescriptions to older adults in primary care. General Hospital Psychiatry, 28, 374–378.Google Scholar
Sorock, G.S., et Shimkin, E.E. (1988). Benzodiazepine sedatives and the risk of falling in a community-dwelling elderly cohort. Archives of Internal Medicine, 148(11), 2441–2444.Google Scholar
Spielberger, C.D. (1983). Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Consulting Psychologist Press.Google Scholar
Swartz, M., Landeman, R., George, L.K., Melville, M., Blazer, D., et Smith, K. (1991). Benzodiazepine anti-anxiety agents: Prevalence and correlates of use in a southern community. American Journal of Public Health, 81, 592–596.Google Scholar
Taylor, S., McCracken, C.F.M., Wilson, K.C.M., et Copeland, J.R.M. (1998). Extent and appropriateness of benzodiazepine use. Results from an elderly urban community. The British Journal of Psychiatry, 173(11), 433–438.Google Scholar
Teng, E.L., Chui, H.C., Hubbard, D., et Corgiat, M.D. (1987). The Modified Mini-Mental State (3MS) test. The Clinical Neuropsychologist, 1, 293.Google Scholar
Tinetti, M.E., Speechley, M., et Gineter, S.F. (1988). Risk factors for falls among elderly persons living in the community. New England Journal of Medicine, 319(26), 1701–1707.Google Scholar
Trafimow, D., et Finlay, K.A. (1996). The importance of subjective norms for a minority of people: Between subjects and within-subjects analyses. Personality and Social Psychology Bulletin, 22, 820–828.Google Scholar
van der Putte, B. (1991). 20 years of the theory of reasoned action of Fishbein and Ajzen. A meta-analysis. Unpublished manuscript, University of Amsterdam.Google Scholar
van Hulten, R., Bakker, A.B., Lodder, A.C., Teeuw, K.B., Bakker, A., et Leufkens, H.G. (2001). Determinants of change in the intention to use benzodiazepines. Pharmacy World & Science, 23(2), 70–75.Google Scholar
van Hulten, R., Bakker, A.B., Lodder, A.C., Teeuw, K.B., Bakker, A., et Leufkens, H.G. (2003). The impact of attitudes and beliefs on length of benzodiazepine use: A study among inexperienced and experienced benzodiazepine users. Social Science & Medicine, 56, 1345–1354.Google Scholar
Voyer, P., Cohen, D., Lauzon, S., et Collin, J. (2004). Factors associated with psychotropic drug use among community-dwelling older persons: A review of empirical studies. BMC Nursing, 3(3–13).Google Scholar
Voyer, P., Cohen, D., Préville, M., Roussel-Roy, M.-È., Berbiche, D., et Béland, S.-G. (2008). Examination of DSM-IV-TR criteria and addiction criteria for benzodiazepine dependance among a random sample of seniors. International Journal of Psychiatric Nursing Research, 14(1), 1–22.Google Scholar
Voyer, P., et Martin, L.S. (2003). Improving geriatric mental health nursing care: Making a case for going beyond psychotropic medications. International Journal of Mental Health Nursing, 13, 11–21.Google Scholar
Voyer, P., Préville, M., Roussel, M.-È., Berbiche, D., et Berland, S.-G. (2009). Factors associated with benzodiazepine dependence among community-dwelling seniors. Journal of Community Health Nursing, 26(3), 101–113.Google Scholar
Williams, K. (2004). The transition to widowhood and the social regulation of health: Consequences for health and health risk behavior. Journal of Gerontology. Series B, Psychological Sciences & Social Sciences, 59(6), S343–349.Google Scholar
Zandstra, S.M., van Rijswijk, E., Rijnders, C., van de Lisdonk, E.H., Bor, J.H.J., van Weel, C., et al. . (2004). Long-term benzodiazepine users in family practice: Differences from short-term users in mental health, coping behaviour and psychological characteristics. Family Practice, 21(3), 266–269.Google Scholar